Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Nycomed seeks European approval for Preotact

April 1, 2005

GH therapy improves insulin sensitivity in postmenopausal women with abdominal obesity

April 1, 2005

Once-monthly Boniva receives FDA approval

March 31, 2005

Depo-subQ provera 104 approved for management of endometriosis pain

March 31, 2005

Takeda discontinues antidiabetic agent TAK-559

March 31, 2005

Dyax updates DX-88 progress for HAE

March 31, 2005

Good safety results for Theratechnologies' GLP-1 analogue

March 30, 2005

Novel human glucagon receptor antagonist discovered

March 30, 2005

Regulatory pathway considered for Vitor in Europe

March 29, 2005

PDE3 inhibitor shows potential clinical use as a contraceptive / News in Context

March 29, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...